Early molecular diagnosis of viral CNS infections is critical for guiding appropriate antiviral therapy and reducing hospitalization and mortality.
No takes yet. Share an insight, caveat, or question.
May support early testing in suspected cases; leaves open prospective validation of outcomes and cost savings.
Smalling et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: